| Location |
Symbol |
Title |
MIM # |
Disorder |
Comments |
Method |
Mouse |
| 3pter-p21 |
CCK |
Cholecystokinin |
118440 |
|
|
REb, REa |
9(Cck) |
| 3pter-p21 |
CX3CR1, GPR13, V28 |
Chemokine (C-X3-C) receptor 1 (G protein-coupled receptor-13) |
601470 |
{Rapid progression to AIDS from HIV1 infection}, 609423 (3);{Coronary artery disease, resistance to}, 607339 (3); {Macular degeneration, age-related, susceptibility to}, 603075 (3) |
|
REa |
|
| 3pter-p14 |
SEP |
SEP transmembrane protein |
601053 |
|
|
REa |
|
| 3p26.2 |
CRBN, MRT2A |
Cereblon |
609262 |
Mental retardation, autosomal recessive 2A, 607417 (3) |
between D3S3525 and D3S1560 |
Fd, REc |
|
| 3p26.2 |
EGO |
Eosinophil granule ontogeny |
611662 |
|
|
REC |
|
| 3p26.2 |
OGG1 |
8-hydroxyguanine DNA glycosylase |
601982 |
Renal cell carcinoma, clear cell, somatic, 144700 (3) |
|
A |
6(Ogg1) |
| 3p26.2 |
OXTR |
Oxytocin receptor |
167055 |
|
3p25 by others; within 7-10kb of CAV3 |
A, Psh |
|
| 3p26.1 |
CHL1, CALL, L1CAM2 |
CHL1, mouse, homolog of (L1 cell adhesion molecule 2) |
607416 |
|
|
A, D |
6(Chl1) |
| 3p26.1 |
EDEM, KIAA0212 |
ER degradation-enhancing alpha-mannosidase-like protein |
607673 |
|
|
R |
|
| 3p26.1-p25.3 |
SCA15 |
Spinocerebellar ataxia 15 |
606658 |
Spinocerebellar ataxia 15 (2) |
between D3S1620 and D3S3691 |
Fd |
|
| 3p26.1-p25.2 |
GRM7, MGLUR7 |
Glutamate receptor, metabotropic, 7 |
604101 |
|
|
R |
|
| 3p26.1-p25.1 |
ARHI2 |
Age-related hearing impairment 2 |
612976 |
{Age-related hearing impairment 2} (2) |
associated with rs11928865, rs779701, and rs779706 |
Fd |
|
| 3p26 |
BHLHB2, STRA13, DEC1 |
Basic helix-loop-helix domain-containing protein, class B, 2 |
604256 |
|
|
A |
|
| 3p26 |
CNTN3, PANG |
Contactin 3 (plasmocytoma-associated neuronal glycoprotein) |
601325 |
|
|
REa, H |
6(Pang) |
| 3p26 |
HPC5 |
Prostate cancer, hereditary, 5 |
609299 |
{Prostate cancer, hereditary, 5}, 176807 (2) |
between D3S1270 and D3S4559 |
Fd |
|
| 3p26 |
IBD9 |
Inflammatory bowel disease 9 |
608448 |
{Inflammatory bowel disease-9}, 266600 (2) |
|
Fd |
|
| 3p26 |
SCA29, CLA4 |
Spinocerebellar ataxia 29 |
117360 |
Spinocerebellar ataxia 29 (2) |
|
Fd |
|
| 3p26 |
SETMAR, METNASE |
SET and Mariner transposase domains-containing protein |
609834 |
|
|
REc |
|
| 3p26 |
STQTL5 |
Stature quantitative trait locus 5 |
608982 |
{Stature QTL 5} (2) |
max lod between D3S1297 and D3S1304 |
Fd |
|
| 3p26 |
SUMF1, FGE |
Sulfatase-modifying factor-1 |
607939 |
Multiple sulfatase deficiency, 272200 (3) |
|
REc, H |
6(Sumf1) |
| 3p26-p25 |
ATP2B2, PMCA2 |
ATPase, Ca++ transporting, plasma membrane, 2 |
108733 |
{Deafness, autosomal recessive 12, modifier of}, 601386 (3) |
|
REa |
|